Browsing: Health

Severe personnel and funding deficits are bottlenecking emergency containment efforts for the Democratic Republic of the Congo’s expanding Ebola epidemic. Driven by the Bundibugyo virus species, the outbreak has swept through six provinces, recording over 6,000 cases and 3,175 fatalities. The World Health Organization is appealing to international donors for urgent financial support to deploy frontline medical teams and scale up isolation capacity across remote eastern corridors.

The World Health Organization has expanded testing, treatment, and field operations in affected areas. WHO has delivered more than 330 tonnes of emergency supplies and deployed over 300 specialists. Currently, health agencies operate 24 laboratories closer to affected communities, a significant increase from the single national reference lab at the start of the response. Daily testing capacity has increased to roughly 3,000 tests, and treatment and isolation beds now exceed 1,300 across 49 facilities. The Bundibugyo virus currently has no approved vaccine or targeted treatment. Researchers are engaged in therapeutic trials, and two vaccine candidates are in safety testing phases. Health teams continue contact tracing, testing, clinical management, infection prevention, and safe burial practices. Authorities are also scaling up community engagement efforts, recognizing that delays in detection can leave infected individuals outside formal monitoring systems, complicating efforts to identify transmission chains promptly. Transmission persists despite declining case numbers Transmission remains active in 51 health zones, even though recent weeks have seen a reduction in case counts. Four zones have not reported new infections for over 42 days and have effectively interrupted transmission. Additionally, five zones have experienced between 21 and 42 days without new cases. Public health officials caution that the recent decline does not yet confirm that the outbreak is under control, but surveillance continues across all affected regions.

The outbreak affects 60 health zones within six provinces. Authorities also report 1,439 recoveries, with a case fatality rate of 48.6%.Health teams in Congo continue Ebola testing, contact tracing and treatment. The Bundibugyo Ebola epidemic has become Congo’s most significant and deadly outbreak to date. It is also the second-largest Ebola epidemic globally, following the 2014-2016 outbreak in West Africa.

Health authorities in the Democratic Republic of the Congo started administering Ebola vaccines in Kisangani on Thursday, initiating a targeted effort in Tshopo Province’s capital to protect frontline responders. The campaign focuses on healthcare workers, emergency response teams, and people with direct contact with confirmed patients as the country faces its most severe Ebola outbreak to date. Health Minister Samuel-Roger Kamba confirmed that the government distributed an initial batch of the Ervebo vaccine under a compassionate-use protocol across affected eastern provinces to safeguard essential personnel and help interrupt viral spread.

The European Commission has bolstered its efforts against Ebola by securing a €2.1 million supply of PCR tests aimed at the Bundibugyo virus outbreak. The procurement involves open-platform tests compatible with existing laboratory systems. The European Health and Digital Executive Agency facilitated the purchase. The first shipments are expected to arrive in August, as health teams respond to a significant outbreak centered in the Democratic Republic of the Congo, impacting surrounding regions.

The Democratic Republic of the Congo has acquired a supply of 70,000 Ebola vaccine doses as its Bundibugyo outbreak expands. Health officials reported 5,208 confirmed cases and 2,476 fatalities as of Aug. 18. The epidemic now affects 56 health zones across six provinces. Authorities have also documented 1,115 recoveries. Additionally, 730 patients remain in isolation or hospital care as response teams operate within affected communities in eastern and northeastern DR Congo.

World Health Organization estimates that the Ebola outbreak in the Democratic Republic of the Congo could be brought under control within three months if adequate resources are provided. As of Aug. 16, official data reported 5,021 confirmed cases and 2,378 fatalities. The virus has spread across six provinces and 55 health zones, with a case fatality rate of approximately 47%. This marks it as the deadliest Ebola outbreak ever recorded in the country.WHO and Congo health teams strengthen surveillance amid the expanding Ebola outbreak. (AI-generated image)According to WHO incident manager Thierno Baldé, the timeline for containment hinges on maintaining sufficient staffing, supplies, and operational support. So far, the response has secured about $69.3 million of the $115 million needed. Over a two-week span, health teams have added more than 400 treatment beds, deployed 100 additional epidemiologists, and mobilized over 500 community health workers to assist with surveillance, contact tracing, case detection, and referrals. The response also relies on ambulances, vehicles, medical supplies, and trained personnel in affected regions.

In 2025, the Democratic Republic of the Congo documented 26,064,143 malaria cases, highlighting the widespread nature of the disease across the nation. During the same year, health officials also recorded 29,938 deaths linked to malaria. Guy Esebe Dembo, deputy director of the National Malaria Control Programme, presented these statistics at the launch of a mass treatment initiative in Ituri province. The campaign aims to address regions where malaria remains a leading cause of illness and places substantial pressure on healthcare systems.

International relief agencies monitor cross border health screening checkpoints along transit routes. Data from the Ministry of Health of the Democratic Republic of the Congo reveal that more than 4,500 confirmed cases have caused over 2,100 deaths. Although authorities officially declared the epidemic on May 15, genomic analysis later indicated that undetected community transmission had started as early as February. Public health experts highlight that the death toll was reached nearly three times faster than during previous large-scale outbreaks, underscoring the severe operational challenges in tracing active infection chains across isolated regions. A major factor fueling the escalation is the particular viral strain responsible. Unlike recent outbreaks driven by Zaire ebolavirus, this epidemic is caused by the rare Bundibugyo ebolavirus strain, which currently lacks licensed vaccines or approved treatments. While experimental therapies are under clinical trials in Ituri province under international oversight, field clinics operated in collaboration with Médecins Sans Frontières primarily provide supportive care, oral rehydration, and intensive symptom management.

The Ebola outbreak in the Democratic Republic of the Congo has resulted in 1,916 fatalities, according to official data up to Aug. 7. The authorities have verified 4,209 cases during this period. This latest figure surpasses the previous total of 1,887 by 29 deaths. Additionally, 595 patients are receiving treatment in isolation, while 828 individuals have recovered.